Amphastar Pharmaceuticals, Inc. — Director's Dealing 2014

Jun 25, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2014-06-24

Reporting Person: PETERS WILLIAM J (CFO, Sr VP & Treasurer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14722	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$14.4	2024-04-21	Common Stock (118553)		Direct

Footnotes

F1: This represents deferred stock units that were granted on 4/21/2014 and vest over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.

F2: This option was granted on 4/21/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.